Mutation or Loss of P53 Differentially Modifies TGFβ Action in Ovarian Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0089553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Frequent Mutation of the P53 Gene in Human Esophageal Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Identification of Differentially Expressed snoRNAs in Ovarian Cancer From RNA-Seq Data

Canadian Journal of Biotechnology
2017English

Pre-Test Prediction Models of BRCA1 or BRCA2 Mutation in Breast/Ovarian Families Attending Familial Cancer Clinics

Journal of Medical Genetics
Genetics
2003English

Sex Differences in Cancer Risk Among Germline P53 Mutation Carriers

British Journal of Cancer
Cancer ResearchOncology
2004English

Constitutional P53 Mutation in a Non-Li-Fraumeni Cancer Family

British Journal of Cancer
Cancer ResearchOncology
1992English

Deficiency of G1 Regulators P53, P21Cip1and/or pRb Decreases Hepatocyte Sensitivity to TGFβ Cell Cycle Arrest

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Ovarian Cancer Screening in Menopausal Females With a Family History of Breast or Ovarian Cancer

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy